Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges

Increasing life expectancy has led to an aging population, which has consequently increased the prevalence of dementia. Alzheimer's disease (AD), the most common form of dementia worldwide, is estimated to make up 50–80% of all cases. AD cases are expected to reach 131 million by 2050, and this...

Descripción completa

Detalles Bibliográficos
Autores principales: Cano, Amanda, Turowski, Patric, Ettcheto, Miren, Duskey, Jason Thomas, Tosi, Giovanni, Sánchez-López, Elena, García, Maria Luisa, Camins, Antonio, Souto, Eliana B., Ruiz, Agustín, Marquié, Marta, Boada, Mercè
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086346/
https://www.ncbi.nlm.nih.gov/pubmed/33926475
http://dx.doi.org/10.1186/s12951-021-00864-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086346/
https://www.ncbi.nlm.nih.gov/pubmed/33926475
http://dx.doi.org/10.1186/s12951-021-00864-x

Ejemplares similares